In Vitro ADMET Laboratories (“IVAL”) has been sold to Discovery Life Sciences™. Headquartered in Columbia, Maryland, IVAL is an industry-leading provider of physiologically relevant in vitro experimental systems to enhance the efficiency of drug metabolism, toxicology, and pharmacology testing for the pharmaceutical industry.

Discovery Life Sciences, headquartered in Huntsville, Alabama, is the company of Biospecimen and Biomarker Specialists™, combining the world’s largest commercial biospecimen inventory and procurement network with preeminent multi-omic biomarker service laboratories to accelerate new therapies supported by biomarker and companion diagnostic programs for cancer, infectious disease, and other rare and complex conditions.

EC M&A acted as exclusive financial advisor to IVAL on this transaction.